(PIP:Consolidated issues listed on NYSE MKT LLC)
Mitchel B. Sayare Ph.D.
Chairman, Chairman of Governance & Nominating Committee and Member of Compensation Committee, PharmAthene, Inc.
|Age||Total Calculated Compensation||This person is connected to 126 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Dr. Mitchel B. Sayare, Mitch, Ph.D. served as the Chief Executive Officer of ImmunoGen Inc. (a biotechnology company) from 1986 to January 1, 2009 and as its President from 1994 to July 29, 2008. From 1986 to 1992, Dr. Sayare served as the President of ImmunoGen Inc. From 1982 to 1985, Dr. Sayare served as a Vice President of Development at Xenogen Inc. Dr. Sayare has been the Chairman of PharmAthene, Inc. since July 15, 2011. Dr. Sayare served as the Chairman of the ...
One Park PlacePhone: 410-269-2600
Annapolis, Maryland 21401
Board Members Memberships*
Former Director, Chairman of Audit Committee and Member of Nominating Committee
Chairman, Chairman of Governance & Nominating Committee and Member of Compensation Committee
Temple University School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Christopher J. Schaber Ph.D.||Chairman, Chief Executive Officer and President|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|John Anthony Sedor||Chief Executive Officer, President and Non-Independent Director|
|Anders Hedegaard MSc||Chief Executive Officer and President|
Bavarian Nordic A/S
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$860.3K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26